e-Drug3D

849

KETOTIFEN


INN
KETOTIFEN

cas 34580-13-7
CLASS

RESPIRATORY
ANTIASTHMATIC
ANTI-ALLERGIC AGENTS
ANTIPRURITICS
HISTAMINE H1 ANTAGONISTS

ROUTE (list)

OPHTHALMIC

ATC code

R06AX17
S01GX08

PK parameters

F 60 PERCENT
VD 175.5 LITER (65 KILOGRAM)
PPB 70 PERCENT
t1/2 21 HOUR

Target

TARGET HISTAMINE H1 RECEPTOR

DrugCentral

Histamine H1 receptor UNIPROT P35367 HRH1

Download SDF file 10H-Benzo[4,5]cyclohepta[1,2-b]thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-

Formula:
C19H19NOS

Calculated chemical properties:

MW 309.42
NB_atoms 22
XLogP 4.01
PSA 23.229
NB_HD 0
NB_HA 2
fsp3 0.32
Lipinski(0=no;1=yes) 1

FDA
NDA 021066 (label) INN (KETOTIFEN FUMARATE) ZADITOR (ALCON PHARMA) APPROVAL= AP YEAR= 1999 NEWMOLECULARENTITY DISCONTINUED
NDA 021996 (label) INN (KETOTIFEN FUMARATE) ALAWAY (BAUSCH AND LOMB) APPROVAL= AP YEAR= 2006
NDA 077354 (pdf not found) INN (KETOTIFEN FUMARATE) KETOTIFEN FUMARATE (APOTEX INC) APPROVAL= AP YEAR= 2006 DISCONTINUED
NDA 077958 (pdf not found) INN (KETOTIFEN FUMARATE) KETOTIFEN FUMARATE (SENTISS) APPROVAL= AP YEAR= 2007
NDA 077200 (pdf not found) INN (KETOTIFEN FUMARATE) ZADITOR (ALCON PHARMS LTD) APPROVAL= AP YEAR= 2008
NDA 204059 (pdf not found) INN (KETOTIFEN FUMARATE) KETOTIFEN FUMARATE (UNICHEM) APPROVAL= AP YEAR= 2020
NDA 208158 (pdf not found) INN (KETOTIFEN FUMARATE) ALAWAY (BAUSCH AND LOMB INC) APPROVAL= AP YEAR= 2020 DISCONTINUED
NDA 022388 (label) INN (KETOTIFEN FUMARATE) ACUVUE THERAVISION WITH KETOTIFEN (JOHNSON JOHNSON VISN) APPROVAL= AP YEAR= 2022 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL